President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

A small and financially opaque drug research nonprofit group based in Ohio has managed to get its research cited extensively in high-prestige publications such as the New York Times, Wall Street ...